You may have to Search all our reviewed books and magazines, click the sign up button below to create a free account.
This 8th Edition of Moss and Adams' Heart Disease in Infants, Children, and Adolescents: Including the Fetus and Young Adult, provides updated and useful information from leading experts in pediatric cardiology. Added chapters and a companion web site that includes the full text with bonus question and answer sections make this Moss and Adams’ edition a valuable resource for those who care for infants, children, adolescents, young adults, and fetuses with heart disease. Features: · Access to online questions similar to those on the pediatric cardiology board examination to prepare you for certification or recertification · Leading international experts provide state-of-the-art diagnostic and interventional techniques to keep you abreast of the latest advances in treatment of young patients · Chapters on quality of life, quality and safety, pharmacology, and research design add to this well-respected text
Recommended in the Brandon/Hill selected list of print books and journals for the small medical library - April 2003 Updated throughout, the Sixth Edition of Moss and Adams' Heart Disease in Infants, Children, and Adolescents: Including the Fetus and Young Adult continues to be the primary cardiology text for those who care for infants, children, adolescents, young adults, and fetuses with heart disease. The most comprehensive text in the field, the text covers basic science theory through clinical practice of cardiovascular disease in the young with information being updated to reflect the la.
There are growing questions regarding the safety, quality, risk management, and costs of PCC teams, their training and preparedness, and their implications on the welfare of patients and families. This innovative book, authored by an international authorship, will highlight the best practices in improving survival while paving a roadmap for the expected changes in the next 10 years as healthcare undergoes major transformation and reform. An invited group of experts in the field will participate in this project to provide the timeliest and informative approaches to how to deal with this global health challenge. The book will be indispensable to all who treat pediatric cardiac disease and will provide important information about managing the risk of patients with pediatric and congenital cardiac disease in the three domains of: the analysis of outcomes, the improvement of quality, and the safety of patients.
Established since 1968 as a classic pediatric cardiology text, this two-volume work is now in its Seventh Edition. Leading international experts describe state-of-the-art diagnostic and interventional techniques for young patients with congenital and acquired heart diseases and for adult survivors of congenital heart disease. This edition's section on pediatric cardiac intensive care has new chapters on interventricular and cardiopulmonary interactions and on the extreme premature, premature, and normal newborn. A section From the Gene to the Neonate provides in-depth coverage of genetics, fetal echocardiography, and fetal cardiology. An extensive section focuses on adult survivors of congenital heart disease. A companion Website will include the fully searchable online text and a full-color image bank.
The 9th edition of the gold standard in pediatric cardiology offers up-to-date, comprehensive coverage of this challenging and rapidly changing field. New chapters based on reader requests, two new associate editors, new contributing authors, and an enhanced digital version of the text make Moss and Adams’ Heart Disease in Infants, Children, and Adolescents the reference you’ll turn to when caring for patients. From cover to cover, this award-winning two-volume resource provides the authoritative, state-of-the-art information you need when caring for young patients with heart disease. New, reader-requested chapters cover Development of Myocardial Structure and Function, Global Challenge ...
Current heart failure therapeutics affects symptoms without appreciably reducing the mortality rate of 50% in five years -- suggesting a failure in treating the underlying mechanism. This book proposes a new mechanism for heart failure; immune mediated cardiac remodelling for cardiac dysfunction. The outstanding editor team of two internationally recognized immunologists -- Ronald Watson, who has studied heart disease in immune dysfunction for a decade and has a patent for an immunotherapy of heart disease by immune regulation, and Douglas Larson, whose experience in cardiac transplantation immunology has provided the foundation for research into novel therapeutics for heart failure and hype...